[HT-03] Hot Topics 03「Disseminating New Knowledge from Asia & Oceania」

[HT-03-3] PACTRIMS addresses challenges of multiple sclerosis and related disorders in Asia

Kazuo Fujihara^1,2 (1.Multiple Sclerosis and Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience, Japan, 2.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine, Japan)

1984: graduated from Kyushu University Faculty of Medicine
1991~1994: Neuroimmunology Fellow, Roswell Park Cancer Institute and State University of New York at Buffalo
2013~present: Board member, European Charcot Foundation
2013-present, Executive Committee member, International Medical and Scientific Board of The Multiple Sclerosis International Federation
2015~present: Professor, Department of Multiple Sclerosis Therapeutics, Fukushima Medical University and Director, Mutiple Sclerosis and Neuromyelitis Optica Center, Southern TOHOKU Research Institute for Neuroscience
2019~present: President, Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS)
2019~2022: President, Japanese Society of Neuroimmunology
2021~present: Board member (ex officio), American Society of Experimental Neurotherapeutics
2022~present: member, International Advisory Committee on Clinical Trials in MS
member of International Panels on Diagnosis of MS 2010 and 2017, NMOSD 2015 and 2025, MOGAD 2023